Gaas, Erwin N.
HRN: 16-07-93 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/23/2024
CEFTAZIDIME 1GM (VIAL)
01/23/2024
01/30/2024
IV
2g
Q8hrs
Empiric
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes